Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DCA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,832
Award facts
- Contract value 100% obligated
- $11,831.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,831.65 to AmerisourceBergen Drug Corp for COSENTYX (secukinumab) 300 mg pen 2ml on January 13, 2026, with an ultimate completion date of January 14, 2026. This is a firm fixed-price, non-set-aside contract for a pharmaceutical product used in the treatment of autoimmune conditions. The contract was competitively awarded and represents a single task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. As a child entity of parent company Cencora, Inc. (doing business as AmerisourceBergen), the awardee has demonstrated extensive capability in fulfilling federal medical supply needs through its existing contract portfolio with the Defense Logistics Agency. The company's SPE2DX IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and the U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F9DCA?
SPE2DR26F9DCA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9DCA worth?
The government has obligated $11,832 on SPE2DR26F9DCA.
Is contract SPE2DR26F9DCA an order under another contract?
Yes. SPE2DR26F9DCA is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DCA competed?
The extent of competition for SPE2DR26F9DCA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award